LILRB1 and neoplasm: For instance, binding between HLA class I on cancer cells and leukocyte immunoglobulin-like receptor 1 (LILRB1) expressed on monocytes, dendritic cells, and tumor-associated macrophages transduces an inhibitory signal that blocks phagocytosis [94,95].